Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
89029158 | 8902915 | 8 | F | 200511 | 20160726 | 20121112 | 20160728 | EXP | US-009507513-1211USA004403 | MERCK | 0.00 | F | Y | 0.00000 | 20160728 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
89029158 | 8902915 | 1 | PS | FOSAMAX | ALENDRONATE SODIUM | 1 | Oral | 70 MG, UNK | 20560 | 70 | MG | TABLET | |||||||
89029158 | 8902915 | 2 | SS | FOSAMAX | ALENDRONATE SODIUM | 1 | Oral | 70 MG, QW | 20560 | 70 | MG | TABLET | /wk | ||||||
89029158 | 8902915 | 3 | SS | ALENDRONATE SODIUM. | ALENDRONATE SODIUM | 1 | Oral | 70 MG, QW | 20560 | 70 | MG | TABLET | /wk | ||||||
89029158 | 8902915 | 4 | SS | ACTONEL | RISEDRONATE SODIUM | 1 | Oral | 150 MG, UNK | 0 | 150 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
89029158 | 8902915 | 1 | Osteoporosis |
89029158 | 8902915 | 3 | Osteoporosis |
89029158 | 8902915 | 4 | Osteoporosis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
89029158 | 8902915 | DS |
89029158 | 8902915 | HO |
89029158 | 8902915 | OT |
89029158 | 8902915 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
89029158 | 8902915 | Adverse event | |
89029158 | 8902915 | Anaemia of chronic disease | |
89029158 | 8902915 | Anaemia postoperative | |
89029158 | 8902915 | Arteriosclerosis | |
89029158 | 8902915 | Atrial fibrillation | |
89029158 | 8902915 | Blood osmolarity decreased | |
89029158 | 8902915 | Cardiac failure congestive | |
89029158 | 8902915 | Cardiopulmonary failure | |
89029158 | 8902915 | Chronic kidney disease | |
89029158 | 8902915 | Constipation | |
89029158 | 8902915 | Decreased appetite | |
89029158 | 8902915 | Dyspnoea | |
89029158 | 8902915 | Fall | |
89029158 | 8902915 | Femur fracture | |
89029158 | 8902915 | Fungal oesophagitis | |
89029158 | 8902915 | Gastrooesophageal reflux disease | |
89029158 | 8902915 | Hip arthroplasty | |
89029158 | 8902915 | Hypertension | |
89029158 | 8902915 | Hyponatraemia | |
89029158 | 8902915 | International normalised ratio increased | |
89029158 | 8902915 | Intestinal ischaemia | |
89029158 | 8902915 | Joint arthroplasty | |
89029158 | 8902915 | Joint effusion | |
89029158 | 8902915 | Joint swelling | |
89029158 | 8902915 | Leukocytosis | |
89029158 | 8902915 | Macular degeneration | |
89029158 | 8902915 | Neuroma | |
89029158 | 8902915 | Open reduction of fracture | |
89029158 | 8902915 | Palpitations | |
89029158 | 8902915 | Peptic ulcer | |
89029158 | 8902915 | Peripheral swelling | |
89029158 | 8902915 | Renal failure | |
89029158 | 8902915 | Toxicity to various agents | |
89029158 | 8902915 | Transient ischaemic attack | |
89029158 | 8902915 | Upper-airway cough syndrome | |
89029158 | 8902915 | Urinary incontinence | |
89029158 | 8902915 | Vaginal infection | |
89029158 | 8902915 | Vision blurred | |
89029158 | 8902915 | Vitamin D deficiency | |
89029158 | 8902915 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
89029158 | 8902915 | 1 | 2001 | 200809 | 0 | |
89029158 | 8902915 | 2 | 200306 | 2008 | 0 | |
89029158 | 8902915 | 3 | 200805 | 200808 | 0 | |
89029158 | 8902915 | 4 | 200809 | 200812 | 0 |